Rabies virus in raccoons, Ohio, 2004.

In 2004, the raccoon rabies virus variant emerged in Ohio beyond an area where oral rabies vaccine had been distributed to prevent westward spread of this variant. Our genetic investigation indicates that this outbreak may have begun several years before 2004 and may have originated within the vaccination zone.

**********

Several wild carnivorous mammals may be competent zoonotic reservoirs for rabies viruses (1). Similar to how parenteral vaccination has contributed to control and elimination of rabies in dogs, effective oral rabies vaccines and application methods for wildlife species, most notably the red fox (Vulpes vulpes), have led to regional containment and elimination of the rabies virus variants associated with this species in large parts of Canada and Europe (2). The first step toward reducing the size of areas in which rabies is enzootically transmitted is containment of its regional spread. Understanding the conditions under which contaimnent of wildlife rabies can reliably be achieved will facilitate the long-term goal of eliminating particular rabies virus variants from their respective reservoir species.

During the late 1970s, the range of a raccoon (Procyon lotor)--specific rabies virus variant (RRV) expanded substantially from the historically affected southeastern United States to the currently affected eastern North America (3). In 1996, to contain westward expansion of this variant, oral rabies vaccine (ORV) was distributed in Ohio. The ORV strategy includes distributing bait containing a vaccinia-rabies glycoprotein recombinant vaccine (4) while taking advantage of physiogeographic impediments to rabies transmission, such as mountains, rivers, and major highways to create a barrier 50 kin-150 km wide between unaffected and enzootic areas.

During 1999 2004, ORV had apparently limited further spread of the virus (5) (Figure 1). However, in July 2004, RRV was diagnosed in a raccoon northwest of the ORV zone in Lake County, Ohio. As of December 2005, enhanced surveillance had detected 77 rabid raccoons in Lake County and 2 adjacent counties (Geauga and Cuyahoga) (Figures 1 and 2, panel A). These detections raised the question whether current ORV and surveillance strategies are sufficient for containment and reaching the long-term goal of regional elimination of RRV. We used molecular analyses to gain insight into the factors and possible raccoon source populations associated with the breach of the ORV zone in Ohio.

The Study

Viral RNA was extracted as described (6) from brain tissue of 67 rabid raccoons. Samples came from raccoons in Ohio (1996 [n = 9] and 2004 [n = 10] outbreaks) and the neighboring states of Pennsylvania (2003-2004 [n = 21] and West Virginia (1987-2004 [n = 27]) (online Appendix Table, available from www.cdc.gov/EID/content/14/4/650appT.htm). We amplified a 1,345-nt portion of the glycoprotein gene (G) and, for a smaller subset of samples (n = 20), the complete nucleoprotein gene (N) (1,416 nt,) (see [6] for primers and conditions). Sequences from a Florida raccoon (G, U27216; N, U27220) were included as an outgroup. When sequence data for G and N had been obtained, sequences were concatenated. After alignment, appropriate evolutionary models (7) were found for phylogenetic estimation by using maximum-likelihood and Bayesian approaches (8,9). Maximum-likelihood trees were constructed by using heuristic searches, and node support was assessed with 1,000 bootstrap replicates under the distance criterion with maximum-likelihood model settings. Bayesian estimation was performed with 2 runs of 6 million samples each and a sampling frequency of 1,000; the first 1,000 samples were discarded as burn-in.

A Bayesian molecular clock-based method (10) was used to estimate when the 2004 RRV lineage had started to diversify. To estimate evolutionary rates, we included 3 raccoon rabies sequences isolated during the larger Atlantic coast epizootic of 1982-1984. Analyses were run for 10 million steps after a burn-in period of 1 million under an exponential growth model; alternative demographic models produced equivalent results (data not shown).

According to the combined G and N data, the phylogenetic analyses showed that the 2004 Ohio outbreak was caused by a distinct RRV lineage that had limited diversity (Figure 2, panel B, red), which suggests a single-source introduction into Ohio. The 2004 lineage was not a direct descendent of any previously sampled lineages, but it shared a common ancestor with another lineage (Figure 2, panel B, yellow) that contained the viruses responsible for the 1996 Ohio outbreak along with contemporary viruses from western Pennsylvania. No members of either of these lineages had been found east of the ORV barrier (Figure 2, panel A), an area dominated by a different group of viruses (Figure 2, panel B, blue). The same result was obtained when the larger dataset based on G data only was analyzed (online Appendix Figure, available from www.cdc.gov/EID/ content/14/4/650-appG.htm) and when we included RRV sequences from throughout eastern North America (data not shown). This finding suggests that the virus associated with the 2004 outbreak in Ohio most likely originated within the ORV zone.

[FIGURE 1 OMITTED]

Temporal estimates further indicated that all viruses sampled in the recent Ohio outbreak had started to diversify at least 3 years before 2004. The estimated dates associated with the most recent common ancestor were 1998 (highest posterior density interval 1993-2001) for the concatenated G and N data and 1995 (highest posterior density interval 1990-2000) for G data only.

Conclusions

Our findings imply that RRV had been circulating undetected among raccoons in the ORV zone, and possibly beyond it, for several years before its detection in 2004. These findings have important implications for the control of wildlife rabies in raccoons through ORV. First, the genetic analyses do not point to a long-distance transmission event to Ohio but rather suggest that the virus was indigenous to the region. ]n view of potential continued transmission events within the current ORV zone, widening the ORV corridor likely will not prevent such transmission and further spread. Second, the findings suggest that RRV may be able to persist within the ORV zone for several years and thus provide continued risk for eventual spread into unvaccinated raccoon populations. Insufficient levels of immunization among the overall population could contribute to this situation. However, spatial variation in the level of immunization or random fluctuations in the number of infected animals may also enable the virus to persist in parts of the ORV zone. Third, the level of surveillance needed to detect RRV when transmission frequency is low is unclear.

Our results indicate that the virus had been present within Ohio for several years when surveillance efforts were relatively low; from January 2000 through June 2004, an average of 71 raccoons were tested each month compared with an average of 139 per month during 1997-1999 (Figure 1). Therefore, the critical question is: at what point would the marginal cost of increased surveillance leading to earlier detection have outweighed the cost associated with controlling the 2004 outbreak? To develop the most cost-effective strategy for containment and ultimate elimination of rabies among raccoons, further analyses should aim at quantifying this trade-off.

[FIGURE 2 OMITTED]

Acknowledgments

We thank Thomas Wampler, John Moore, Joshua Hoblet, John Paul Seman, Caleb Wellman, and Kathleen Smith for help with collecting samples. We also thank local health department personnel responsible for picking up animals for enhanced surveillance testing. We are grateful to Charles Rupprecht for helpful discussions, Jesse Blanton for assistance with mapping, and Lillian Orciari and Michael Niezgoda for providing access to archived samples.

Ms Henderson is currently a researcher in the Respiratory, Diseases Branch at the Centers for Disease Control and Prevention in Atlanta, Georgia. Her research interests include molecular biology and virology.

References

(1.) Jackson AC, Wunner WH, editors. Rabies. 2nd ed. London: Academic Press: 2007.

(2.) Rupprecht CE, Hanlon CA, Slate D. Oral vaccination of wildlife against rabies: opportunities and challenges in prevention and control. Dev Biol (Basel). 2004:119:173-84.

(3.) Rupprecht CE, Smith JS. Raccoon rabies: the re-emergence of an cpizootic in a densely populated area. In: Seminars in virology; 1994. p. 155-64.

(4.) Hanlon CA, Niezgoda M, Hamir AN, Schulnacher C, Koprowski H, Rupprecht CE. First North American field release of a vaccinia-rabies glycoprotein recombinant vires. J Wildl Dis. 1998:34:228-39.

(5.) Slate D. Rupprecht CE, Rooney JA, Donovan D, Lein DH, Chipman RB. Status of oral rabies vaccination in wild carnivores in the United States. Virus Res. 2005:111:68-76.

(6.) Biek R, Henderson JC, Waller LA, Rupprecht CE, Real LA. A high-resolution genetic signature of demographic and spatial expansion in cpizootic rabies vires. Proc Natl Acad Sci U S A. 2007;104:7993-8.

(7.) Posada D, Crandall KA. MODELTEST: testing the model of DNA substitution. Bioinformatics. 1998:14:817-8.

(8.) Ronquist F, Huelsenbeck JR MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics. 2003;19:1572-4.

(9.) Swofford DL. PAUP* (Phylogenetic analysis using parsimony) (*and other methods). Version 4.0b10. Sunderland (MA): Sinauer Associates: 2002.

(10.) Drummond AJ, Rambaut A. BEAST (Bayesian evolutionary analysis by sampling trees). BMC Evol Biol. 2007;7:214.

Address for correspondence: Leslie A. Real, Department of Biology and Center for Disease Ecology, Emory University, 1510 Clifton Rd, Atlanta, GA 30322, USA: email: [e-mail]

J. Caroline Henderson, * (1) Roman Biek, * (2) Cathleen A. Hanlon, ([dagger]) Scott O'Dee, ([double dagger]) and Leslie A. Real *

* Emory University, Atlanta, Georgia, USA; ([dagger]) Kansas State University, Manhattan, Kansas, USA; and ([double dagger]) Ohio Department of Health, Reynoldsburg, Ohio, USA

(1) Current affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

(2) Current affiliation: University of Glasgow, Glasgow, Scotland, UK.

Use of trade names is for identification only and does not imply endorsement by the Public Health Service or by the U.S. Department of Health and Human Services.